ORTSSPEZIFISCHE INTEGRATION

Patent europeic · EP2864489 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP2864489
Numer da la dumonda
EP13729962
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
20-06-2013
Publitgà
29-04-2015
Concedì
29-03-2017
Stritgà
30-06-2017
Motiv
Taxa annuala betg pajada
Classas IPC
C12N 15/90 (2006.01)
C12N 5/10 (2006.01)
C12N 15/10 (2006.01)
Prioritad
US 201261663147 P 22.06.2012
EP 12185330 21.09.2012
Dumonda PCT
PCT/EP2013/062859 20.06.2013
Publicaziun PCT
WO2013/190032 27.12.2013
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 24-01-2018

    Stritgà, taxa betg pajada

    Published in Swissreg on 24.01.2018

  2. 29-03-2017

    Concedì

    Published in Swissreg on 29.03.2017

Partidas

Possessur

Lonza Biologics plc

Lonza Biologics Plc.

228-230 Bath Road, Slough SL1 4DX, GB

Pfizer Inc.

235 East 42nd Street, New York, NY 10017, US

Inventur

RANCE, James

Thame Oxfordshire OX9 3TJ, GB

YOUNG, Robert

London Greater London NW2 1SR, GB

AGOSTINO, Michael J.

Andover, MA 01810, US

MOFFAT, Mark

Saint Louis, MO 63109, US

ZHANG, Lin

Boxford, MA 01921, US

ZHANG, Baohong

Needham, MA 02492, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.